Gossamer Bio(GOSS.US)

Last Updated 19:00:00 ET
longbridge loading

U.S. stock night trading volatility: Gossamer Bio rose 5.19% in after-hours trading, boosted by dual positive factors of debt restructuring and successful trials enhancing market confidence

Price Alert·
US
GOSS
+5.60%
Price Alert·
US
GOSS
+5.60%

GOSS 2-WEEK DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

PR Newswire·
US
GOSS
+5.60%
US
BBH
-0.36%
US
XBI
-1.61%
PR Newswire·
US
GOSS
+5.60%
US
BBH
-0.36%
US
XBI
-1.61%

Gossamer Bio Reports Q1 2026 Results: Full Earnings Call Transcript

benzinga_article·
US
GOSS
+5.60%
US
XBI
-1.61%
US
SBIO
-2.06%
benzinga_article·
US
GOSS
+5.60%
US
XBI
-1.61%
US
SBIO
-2.06%

Here are the major earnings after the close Monday

MSN·
US
GOSS
+5.60%
US
AGYS
+29.66%
US
MUFG
+1.46%
MSN·
US
GOSS
+5.60%
US
AGYS
+29.66%
US
MUFG
+1.46%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
GOSS
+5.60%
US
LTRN
-1.67%
US
AIM
-16.00%
benzinga_article·
US
GOSS
+5.60%
US
LTRN
-1.67%
US
AIM
-16.00%

Gossamer Bio Restructures Debt and Advances Seralutinib Program

Tip Ranks·
US
GOSS
+5.60%
US
SBIO
-2.06%
US
IHE
+0.46%
Tip Ranks·
US
GOSS
+5.60%
US
SBIO
-2.06%
US
IHE
+0.46%

Gossamer Bio Enters Noteholder Support Pact to Advance Convertible Notes Exchange

TradingView·
US
GOSS
+5.60%
TradingView·
US
GOSS
+5.60%
© 2026 Longbridge｜Disclaimer